Strata Critical Medical, Inc. (NASDAQ:SRTA)
| Market Cap | 397.59M-7.5% |
| Revenue (ttm) | 255.97M+0.6% |
| Net Income | 40.22M+311.9% |
| EPS | 0.50+315.5% |
| Shares Out | 86.53M |
| PE Ratio | 9.24 |
| Forward PE | 1378.64 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 260,368.397 |
| Open | 4.65 |
| Previous Close | 4.68 |
| Day's Range | 4.56 - 4.65 |
| 52-Week Range | 3.95 - 6.50 |
| Beta | 2.43 |
| Analysts | Buy |
| Price Target | 7.25(+57.78%) |
| Earnings Date | Nov 9, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About SRTA
Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$SRTA stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in SRTA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SRTA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SRTA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
SRTA Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Logistics | $48.24M | 66.53% |
| Clinical | $24.27M | 33.47% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New SRTA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SRTA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in SRTA
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $11.52M |
| IWMiShares Russell 2000 ETF | $8.40M |
| VXFVanguard Extended Market ETF | $4.54M |
| DFASDimensional - US Small Cap ETF | $3.15M |
| VTWOVanguard Russell 2000 ETF | $2.22M |
| DFACDimensional - US Core Equity 2 ETF | $1.72M |
Estimated from each fund’s disclosed top holdings × AUM
SRTA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from SRTA’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score